Cargando…
Sorafenib and docosahexaenoic acid act in synergy to suppress cancer cell viability: a role of heme oxygenase 1
BACKGROUND: Docosahexaenoic acid (DHA) is a long chain n-3 polyunsaturated fatty acid that has anticancer activity. Heme oxygenase 1 (HO-1) is a potential therapeutic target due to its cytoprotective activity in cancer cells. We recently reported that DHA induces HO-1 gene transcription in human can...
Autores principales: | Jiao, Yang, Watts, Tanya, Xue, Jing, Hannafon, Bethany, Ding, Wei-Qun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204058/ https://www.ncbi.nlm.nih.gov/pubmed/30367621 http://dx.doi.org/10.1186/s12885-018-4946-9 |
Ejemplares similares
-
Docosahexaenoic acid and disulfiram act in concert to kill cancer cells: a mutual enhancement of their anticancer actions
por: Jiao, Yang, et al.
Publicado: (2017) -
Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA)
por: Hannafon, Bethany N., et al.
Publicado: (2015) -
Suppression of Urokinase-Type Plasminogen Activator Receptor by Docosahexaenoic Acid Mediated by Heme Oxygenase-1 in 12-O-Tetradecanoylphorbol-13-Acetate-Induced Human Endothelial Cells
por: Lian, Sen, et al.
Publicado: (2020) -
Heme Oxygenase-1 Deficiency
por: Renji, Soumya, et al.
Publicado: (2021) -
Heme oxygenase 1 alleviates nonalcoholic steatohepatitis by suppressing hepatic ferroptosis
por: Yuan, Xiwei, et al.
Publicado: (2023)